OrbiMed to invest $200M in Israeli firms
Middle East • April 2011 • Views: 435
World’s leading asset management firm in health sciences industry signs agreement with Israeli government to invest in research and development, focusing on biotechnology.
It’s now to the point that if you are sick, you need Israel.